mixed kinase inhibitors (Celgene)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namemixed kinase inhibitors (Celgene)
Drug Alias NameMKi compounds (Celgene)CC-001CC-004
ClassificationSmall molecules
Mechanisms of ActionProtein kinases inhibitorsPhosphodieterase 4 inhibitorsAnticancer protein kinase inhibitors
TargetsProtein kinasesPhosphodieterase 4
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A